Sinonin Biotech GmbH
DEP2716.HRB210521
Headquarters
Marienstr. 15
27299 Langwedel
Lower Saxony
Germany
Contact
Management
Seronei Chelulei Cheison
Managing Director
Since August 22, 2022
Financials
| Year | Revenue | Earnings | Balance Total | Equity Ratio |
|---|---|---|---|---|
| 2024 | ~210.000 € | 0 € | 128.350 € | 33.8% |
| 2023 | ~66.000 € | 0 € | 33.059 € | 77.9% |
| 2022 | ~35.000 € | 0 € | 15.871 € | 50.9% |
Industry
NACE 72.11Research and experimental development on biotechnologyWZ 72.11.0Research and experimental development on biotechnologyISIC 7210Research and experimental development on natural sciences and engineeringNAICS 541713Scientific Research and Development ServicesNAICS 541714Scientific Research and Development ServicesNAICS 541715Scientific Research and Development ServicesUKSIC 72.11Research and experimental development on biotechnologyNACE2025 72.10Research and experimental development on natural sciences and engineering
Raw Data
{
"id": "00f26cc6-bc19-45d4-b593-c6536e5df15e",
"euId": "DEP2716.HRB210521",
"name": "Sinonin Biotech GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2022-08-22T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Marienstr. 15",
"city": "Langwedel",
"zipCode": "27299",
"state": "NI",
"country": "DE",
"latitude": 52.9744167,
"longitude": 9.1925972
},
"contactData": {
"emails": [],
"phones": [],
"websites": [
"https://www.sinoninbio.tech"
],
"faxes": []
},
"managers": [
{
"name": "Seronei Chelulei Cheison",
"position": "Managing Director",
"startDate": "2022-08-22T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"7210"
],
"nace": [
"72.11"
],
"nace2025": [
"72.10"
],
"naics": [
"541713",
"541714",
"541715"
],
"uksic": [
"72.11"
],
"wz": [
"72.11.0"
]
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 500,
"capitalIsEstimate": false,
"balanceTotal": 15871.03,
"balanceTotalIsEstimate": false,
"earnings": 0,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 35000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 0,
"returnOnSalesIsEstimate": false,
"equity": 8081.43,
"equityIsEstimate": false,
"equityRatio": 50.919379523572196,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 3684.72,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 500,
"capitalIsEstimate": false,
"balanceTotal": 33058.87,
"balanceTotalIsEstimate": false,
"earnings": 0,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 66000,
"revenueIsEstimate": true,
"revenueCagr": 88.57142857142857,
"revenueCagrIsEstimate": true,
"returnOnSales": 0,
"returnOnSalesIsEstimate": false,
"equity": 25749.42,
"equityIsEstimate": false,
"equityRatio": 77.88959513740184,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 1269.57,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 500,
"capitalIsEstimate": false,
"balanceTotal": 128350.22,
"balanceTotalIsEstimate": false,
"earnings": 0,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 210000,
"revenueIsEstimate": true,
"revenueCagr": 144.9489742783178,
"revenueCagrIsEstimate": true,
"returnOnSales": 0,
"returnOnSalesIsEstimate": false,
"equity": 43384.64,
"equityIsEstimate": false,
"equityRatio": 33.801765201493225,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 26126.67,
"liabilitiesIsEstimate": false
}
]
}